You are here
First Test Of Ebola Vaccine On Humans In Germany Gets Underway
Primary tabs
ALLIANCE NEWS Nov. 10, 21014
Hamburg - Researchers at the Hamburg University Clinic (UKE) have begun the first tests on humans in Germany of an Ebola vaccine. The vaccine delivered by the World Health Organisation (WHO) is initially to be tested on 30 volunteers over the next six months, the clinic said Monday, noting that tests on animals had been successful.
If all the testing phases in Hamburg go successfully, then it is hoped that the vaccine can start to be employed by the fall of 2015, a UKE spokeswoman said.
It is hoped that the vaccine "rVSV-ZEBOV," (developed in Canada) can provide protection after just a single dose. Additionally, it might prove to be effective if applied immediately after an Ebola infection starts.
Parallel to the UKE research, scientists from the University Clinic of Tuebingen are to start testing the vaccine on volunteers in Gabon. Other studies are underway in the US and are soon to get started up in Switzerland, Hamburg doctors said.
Recent Comments